Saturday, March 15, 2025

Creating liberating content

Oracle Corp’s (NYSE: ORCL)...

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15%...

RTX Corp (NYSE: RTX)...

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03...

GameStop Corp. (NYSE:GME) Quarter...

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after...

Advanced Micro Devices (NASDAQ:AMD)...

Shares of Advanced Micro Devices (NASDAQ:AMD) drops 0.38% in afterhours in last trading...
HomeTagsAlexion Rare Disease

Tag: Alexion Rare Disease

LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Joins...

AstraZeneca (NASDAQ:AZN) Rare Disease, Alexion has signed...

LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Joins Hand with AstraZeneca (NASDAQ:AZN) to Growth In Genomic Medicines

AstraZeneca (NASDAQ:AZN) Rare Disease, Alexion has signed a definitive agreement to purchase Lexington, Mass.-based LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a pioneering genomic medicine company. The proposed purchase seeks to significantly accelerate Alexion's expansion in genomic therapeutics by using LogicBio's unique technology, experienced rare illness R&D team, and pre-clinical development knowledge. A notable mover in today’s trading session is AstraZeneca (NASDAQ:AZN) as the stock opened the most recent session at 28.840 and at the time of writing the last Bid was at 29.295. In the current trading session the stock reached as...

LogicBio Therapeutics, Inc....

AstraZeneca (NASDAQ:AZN) Rare Disease, Alexion has signed a definitive agreement to purchase Lexington, Mass.-based LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a pioneering genomic medicine company. The...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!